Tracy A. Bedrosian

Tracy A. Bedrosian

Auto-generated profile, based on publicly available information

Tracy A. Bedrosian

Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH, United States; Dept. of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, United States

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2017 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
TBT A Bedrosian
T A Bedrosian
RNR J Nelson
R J Nelson
Temporal organization of physiology is critical for human health. In the past, humans experienced predictable periods of daily light and dark driven by the solar day, which allowed for entrainment of intrinsic circadian rhythms to the environmental light–dark cycles. Since the adoption of electric light, however, pervasive exposure to nighttime lighting has blurred the boundaries of day and night, making it more difficult to synchronize biological processes. Many systems are under circadian control, including sleep–wake behavior, hormone secretion, cellular function and gene expression. Circadian disruption by nighttime light perturbs those processes and is associated with increasing incidence of certain cancers, metabolic dysfunction and mood disorders. This review focuses on the role of artificial light at night in mood regulation, including mechanisms through which aberrant light exposure affects the brain. Converging evidence suggests that circadian disruption alters the function of brain regions involved in emotion and mood regulation. This occurs through direct neural input from the clock or indirect effects, including altered neuroplasticity, neurotransmission and clock gene expression. Recently, the aberrant light exposure has been recognized for its health effects. This review summarizes the evidence linking aberrant light exposure to mood.

23 March 2018 in Science
Verified
Journal Article
Closed access
PDF file
TBTracy A. Bedrosian
Tracy A. Bedrosian
CQCarolina Quayle
Carolina Quayle
NNNicole Novaresi
Nicole Novaresi
FGFred. H. Gage
Fred. H. Gage
Genomic plasticity during brain development: Mice genomes contain many mobile retrotransposons. Bedrosian et al. analyzed DNA from the mouse hippocampus during development (see the Perspective by Song and Gleeson). They found that the amount of maternal care in the first few weeks of a mouse pup's life affected the number of copies of the L1 retrotransposon. The experience of maternal care was thus “recorded” in the DNA of these mice pups during a time when the brain was still actively developing. Science , this issue p. 1395 ; see also p. 1330

23 June 2022 in Epilepsia
Verified
Journal Article
Closed access
TBTracy A. Bedrosian
Tracy A. Bedrosian
KMKatherine E. Miller
Katherine E. Miller
OGOlivia E. Grischow
Olivia E. Grischow
KSKathleen M. Schieffer
Kathleen M. Schieffer
SLStephanie LaHaye
Stephanie LaHaye
DKDaniel C. Koboldt
Daniel C. Koboldt

22 May 1991 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
MKMichael D. Kawaja
Michael D. Kawaja
AFAnne M. Fagan
Anne M. Fagan
Bonnie FiresteinBonnie Firestein
Bonnie Firestein
FGFred H. Gage
Fred H. Gage

28 May 2021 in Brain
Verified
Journal Article
Open access
PDF file
DKDaniel C Koboldt
Daniel C Koboldt
KMKatherine E Miller
Katherine E Miller
AMAnthony R Miller
Anthony R Miller
JBJocelyn M Bush
Jocelyn M Bush
SMSean McGrath
Sean McGrath
TBTracy A Bedrosian
Tracy A Bedrosian
Phosphatase and tensin homologue (PTEN) regulates cell growth and survival through inhibition of the mammalian target of rapamycin (MTOR) signalling pathway. Germline genetic variation of PTEN is associated with autism, macrocephaly and PTEN hamartoma tumour syndromes. The effect of developmental PTEN somatic mutations on nervous system phenotypes is not well understood, although brain somatic mosaicism of MTOR pathway genes is an emerging cause of cortical dysplasia and epilepsy in the paediatric population. Here we report two somatic variants of PTEN affecting a single patient presenting with intractable epilepsy and hemimegalencephaly that varied in clinical severity throughout the left cerebral hemisphere. High-throughput sequencing analysis of affected brain tissue identified two somatic variants in PTEN. The first variant was present in multiple cell lineages throughout the entire hemisphere and associated with mild cerebral overgrowth. The second variant was restricted to posterior brain regions and affected the opposite PTEN allele, resulting in a segmental region of more severe malformation, and the only neurons in which it was found by single-nuclei RNA-sequencing had a unique disease-related expression profile. This study reveals brain mosaicism of PTEN as a disease mechanism of hemimegalencephaly and furthermore demonstrates the varying effects of single- or bi-allelic disruption of PTEN on cortical phenotypes.

1 April 1994 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
JBJames G. Beeson
James G. Beeson
ESEarl R. Shelton
Earl R. Shelton
HCHardy W. Chan
Hardy W. Chan
FGFred H. Gage
Fred H. Gage